Korean ultrasound vendor Medison America (Hall A, #1345) has undergone a major expansion campaign since last year's conference. The Pleasanton, CA, company aspires to break out of its niche in low-end ultrasound with a series of new product introductions
Korean ultrasound vendor Medison America (Hall A, #1345) has undergone a major expansion campaign since last year's conference. The Pleasanton, CA, company aspires to break out of its niche in low-end ultrasound with a series of new product introductions at this year's meeting.
The key to Medison's growth plan is Voluson 530D, an upgraded version of the Combison 530 3-D ultrasound scanner that Medison acquired with its purchase of Kretztechnik in 1996. Medison has added an all-new 128-channel digital beamformer that uses application-specific integrated circuits (ASICs), according to Peter Klein, president and CEO of Medison America. Medison plans to market Voluson 530D as a high-end ultrasound scanner that can also do 3-D imaging, rather than as a dedicated 3-D system, Klein said.
In conventional 2-D ultrasound, Medison also has two new product introductions, both of which are based on digital ultrasound technology. SonoAce 6000 is a lower mid-range system targeted at ob/gyn and surgical applications that will sell for just under $40,000. SonoAce 8800 is a work-in-progress color Doppler scanner with a 64-channel beamformer that will sell for about $80,000. SonoAce 6000 began selling in August, while SonoAce 8800 requires FDA clearance.
Medison also has designs on the MRI market and introduced the 1-tesla Magnum scanner at last year's meeting. This year, the company will feature the addition of fast spin-echo and 3-D gradient-echo sequences for the investigational scanner. Images acquired with the company's new 3-tesla whole-body scanner in South Korea will be displayed.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.